Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberta Bergamo

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of Inorganic Biochemistry|January 9, 2017
Influence of components of tumour microenvironment on the response of HCT-116 colorectal cancer to the ruthenium-based drug NAMI-AAlberta Bergamo, Chiara Pelillo, Angela Chambery, et al.
Dalton Transactions (Cambridge, England : 2003)|May 23, 2012
Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugsGianni Sava, Gérard Jaouen, Elizabeth A Hillard, et al.
Investigational New Drugs|October 24, 2014
Preclinical combination therapy of the investigational drug NAMI-A(+) with doxorubicin for mammary cancerAlberta Bergamo, Tina Riedel, Paul J Dyson, et al.
International Journal of Oncology|November 21, 2008
Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compoundAlberta Bergamo, Alessia Masi, Paul J Dyson, et al.
Journal of Medicinal Chemistry|April 29, 2005
Platinum(II) complexes with antitumoral/antiviral aromatic heterocycles: effect of glutathione upon in vitro cell growth inhibitionParide Papadia, Nicola Margiotta, Alberta Bergamo, et al.
Journal of Cellular Biochemistry|April 11, 2015
Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through α5β1 IntegrinChiara Pelillo, Alberta Bergamo, Hilaria Mollica, et al.
International Journal of Oncology|June 15, 2006
The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapyIsam Khalaila, Alberta Bergamo, Francois Bussy, et al.
Dalton Transactions (Cambridge, England : 2003)|August 20, 2011
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activityIoannis Bratsos, Camilla Simonin, Ennio Zangrando, et al.
Journal of Inorganic Biochemistry|December 8, 2007
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursorsIoannis Bratsos, Alberta Bergamo, Gianni Sava, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
Tumour cell uptake of the metastasis inhibitor ruthenium complex NAMI-A and its in vitro effects on KB cellsFabiana Frausin, Moreno Cocchietto, Alberta Bergamo, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of Inorganic Biochemistry|January 9, 2017
Influence of components of tumour microenvironment on the response of HCT-116 colorectal cancer to the ruthenium-based drug NAMI-AAlberta Bergamo, Chiara Pelillo, Angela Chambery, et al.
Dalton Transactions (Cambridge, England : 2003)|May 23, 2012
Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugsGianni Sava, Gérard Jaouen, Elizabeth A Hillard, et al.
Investigational New Drugs|October 24, 2014
Preclinical combination therapy of the investigational drug NAMI-A(+) with doxorubicin for mammary cancerAlberta Bergamo, Tina Riedel, Paul J Dyson, et al.
International Journal of Oncology|November 21, 2008
Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compoundAlberta Bergamo, Alessia Masi, Paul J Dyson, et al.
Journal of Medicinal Chemistry|April 29, 2005
Platinum(II) complexes with antitumoral/antiviral aromatic heterocycles: effect of glutathione upon in vitro cell growth inhibitionParide Papadia, Nicola Margiotta, Alberta Bergamo, et al.
Journal of Cellular Biochemistry|April 11, 2015
Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through α5β1 IntegrinChiara Pelillo, Alberta Bergamo, Hilaria Mollica, et al.
International Journal of Oncology|June 15, 2006
The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapyIsam Khalaila, Alberta Bergamo, Francois Bussy, et al.
Dalton Transactions (Cambridge, England : 2003)|August 20, 2011
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activityIoannis Bratsos, Camilla Simonin, Ennio Zangrando, et al.
Journal of Inorganic Biochemistry|December 8, 2007
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursorsIoannis Bratsos, Alberta Bergamo, Gianni Sava, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
Tumour cell uptake of the metastasis inhibitor ruthenium complex NAMI-A and its in vitro effects on KB cellsFabiana Frausin, Moreno Cocchietto, Alberta Bergamo, et al.
Pageof 5